CoChat

Exposure and response prevention for obsessive-compulsive disorder: A review and new directions

Open access
Simpson, HBlair, Hezel, DianneM · 2019 · Indian Journal of Psychiatry

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index; 6 of the 39 sources its claims cite were checked for support.

Abstract

Obsessive-compulsive disorder (OCD) is characterized by distressing thoughts and repetitive behaviors that are interfering, time-consuming, and difficult to control. Although OCD was once thought to be untreatable, the last few decades have seen great success in reducing symptoms with exposure and response prevention (ERP), which is now considered to be the first-line psychotherapy for the disorder. Despite these significant therapeutic advances, there remain a number of challenges in treating OCD. In this review, we will describe the theoretical underpinnings and elements of ERP, examine the evidence for its effectiveness, and discuss new directions for enhancing it as a therapy for OCD. © 2019 Indian Journal of Psychiatry.

Overview

CoChat Summary

TL;DR

Exposure and response prevention (ERP) is presented as the first-line psychotherapy for OCD and is supported as highly efficacious, though many patients still do not remit fully or drop out early. The paper reviews how ERP works, summarizes evidence for its effectiveness, and highlights ways to improve access and outcomes.

Key findings

  • A meta-analysis by Eddy et al. found that approximately two-thirds of patients who received ERP experienced symptom improvement, and approximately one-third were considered recovered.
  • The paper states that up to half of people achieve minimal symptoms after acute ERP, but about half of patients do not reach complete symptom remission.
  • Approximately 20–30% of patients drop out of ERP prematurely.
  • In randomized and comparative studies, ERP outperformed relaxation therapy, anxiety management, wait-list, cognitive therapy, and medication-only conditions; one cited study found that after 12 weeks, ERP or ERP plus medication produced greater symptom reduction than clomipramine alone, and adding medication did not improve outcomes over ERP alone.

Methods

  • This is a narrative review of ERP for OCD, organized around the treatment’s elements, efficacy, mechanisms of change, and new directions.
  • The paper synthesizes prior studies across multiple countries, treatment settings, and intensities, including outpatient, partial hospitalization, and residential ERP, as well as internet-delivered ERP and augmentation trials.
  • Main analysis is qualitative synthesis of the literature; the paper reports results from prior meta-analyses, randomized trials, and review articles rather than presenting new primary data.

Limitations

  • The paper states that the mechanism of action remains unclear and that it is still not known exactly how ERP works or why some people respond whereas others do not.
  • The paper notes that many patients drop out prematurely and many who complete ERP still do not achieve a clinically significant reduction of symptoms.
  • Evident from the text: as a review, it does not present new original data and instead depends on the quality and comparability of the cited studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4103/psychiatry.indianjpsychiatry_516_18

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Effectiveness of exposure and response prevention versus other treatments. SRI – Serotonin reuptake inhibitor; ERP – Exposure and response prevention; SMT – Stress management therapy; RIS – Risperidone; symptom severity was assessed with the Yale–Brown Obsessive-Compulsive Scale (Y-BOCS); error bars – Standard error
Figure 1 Effectiveness of exposure and response prevention versus other treatments. SRI – Serotonin reuptake inhibitor; ERP – Exposure and response prevention; SMT – Stress management therapy; RIS – Risperidone; symptom severity was assessed with the Yale–Brown Obsessive-Compulsive Scale (Y-BOCS); error bars – Standard errorCC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 32 Not checked · 4 Own results and interpretations

19 more claims

Create a free account to see all 42 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 5
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 84 references

Cited by

See all 161

Metadata

Authors
Simpson, H., & Hezel, D.
Affiliations
Columbia University Irving Medical Center (US)
Corresponding author
Simpson, HBlair
Venue
Indian Journal of Psychiatry
Published
2019
Volume
61
Issue
7
Pages
85
ISSN
0019-5545 (ISSN-L)
OpenAlex
W2908731132
Cited by
161
References
84
Citations by year
2026: 31 · 2025: 23 · 2024: 38 · 2023: 22 · 2022: 20 · 2021: 14 · 2020: 10 · 2019: 3
FWCI
1.65
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Indian Journal of Psychiatry (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
obsessive-compulsive disorder, exposure and response prevention, cognitive behavioral therapy, treatment effectiveness, treatment enhancement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exposure and response prevention for obsessive-compulsive disorder: A review and new directions. https://app.cochat.ai/papers/10.4103/psychiatry.indianjpsychiatry_516_18
The paper
Simpson, H., & Hezel, D. (2019). Exposure and response prevention for obsessive-compulsive disorder: A review and new directions. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_516_18

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.